EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CD20+ T Cells in Multiple Sclerosis: From Pathogenesis to Treatment-Induced Depletion

Anna Chiara Mazzeo, Laura Calabresi, Valentina Damato iD, Gregorio Spagni, Luca Massacesi, Alice Mariottini iD

International Journal of Molecular Sciences · 11.07.2025 · 26 (14) · 6655

DOI: 10.3390/ijms26146655 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.07.2025. Verfasst von Anna Chiara Mazzeo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, 50139 Florence, Italy. Hauptthemen laut MEDLINE: Multiple Sclerosis, Antigens, CD20, T-Lymphocytes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The traditional paradigm of multiple sclerosis (MS) as a T cell-mediated disorder has been challenged by the effectiveness of monoclonal antibodies (mAbs) targeting CD20-expressing lymphocytes. Although these are mostly represented by B cells, the CD20 marker is expressed by 2–6% of T cells (CD20+ T), which are effectively depleted in serum and cerebrospinal fluid of MS patients by anti-CD20 mAbs. CD20+ T cells are characterized by a pro-inflammatory phenotype and increased potential for migrating and invading the central nervous system (CNS) compared to CD20− T cells. Furthermore, CD20+ T cells are detected within brain inflammatory lesions from MS patients and actively participate in the experimental MS model. This review aims to summarize the current knowledge on CD20+ T cells, from their identification and characterization to evidence of depletion by disease-modifying treatments (DMTs), likely contributing to therapeutic efficacy. Conflicting hypotheses on the origin and development of CD20+ T cells will also be discussed, as well as evidence from clinical and preclinical studies supporting their pathogenetic role in MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisAntigens, CD20T-LymphocytesHumansAnimalsAntibodies, Monoclonal

Stichwörter der Autor:innen

CD20T-Lymphocyte Subsetsantigensautoimmuneautoimmune diseasesencephalomyelitisexperimentalmonoclonal antibodymultiple sclerosis

Substanzen

Antigens, CD20Antibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, 50139 Florence, Italy.
  • Department of Emergency Neurology, Careggi University Hospital, 50139 Florence, Italy.

ORCID-Profile: Valentina Damato, Alice Mariottini

Zitieren

APA

Mazzeo, A. C., Calabresi, L., Damato, V., Spagni, G., Massacesi, L., & Mariottini, A. (2025). CD20+ T Cells in Multiple Sclerosis: From Pathogenesis to Treatment-Induced Depletion. International Journal of Molecular Sciences, 26(14), 6655. https://doi.org/10.3390/ijms26146655

Vancouver

Mazzeo AC, Calabresi L, Damato V, Spagni G, Massacesi L, Mariottini A. CD20+ T Cells in Multiple Sclerosis: From Pathogenesis to Treatment-Induced Depletion. International Journal of Molecular Sciences. 2025;26(14):6655. doi:10.3390/ijms26146655

BibTeX
@article{Mazzeo2025,
  author = {Mazzeo, Anna Chiara and Calabresi, Laura and Damato, Valentina and Spagni, Gregorio and Massacesi, Luca and Mariottini, Alice},
  title = {CD20+ T Cells in Multiple Sclerosis: From Pathogenesis to Treatment-Induced Depletion},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {14},
  pages = {6655},
  doi = {10.3390/ijms26146655}
}
Kostenlos starten →